{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:43Z","timestamp":1791644683933,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejphar.2023.176119","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:57:25Z","timestamp":1697421445000},"page":"176119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin"],"prefix":"10.1016","volume":"960","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-2813","authenticated-orcid":false,"given":"Hanan S.","family":"Anbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0127-4363","authenticated-orcid":false,"given":"Nisha Yarifbhai","family":"Vahora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajra laghman","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariyam Mohammed","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamanna","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-8149","authenticated-orcid":false,"given":"Hany A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Dohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry V.L.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed I.","family":"El-Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176119_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40738-020-00074-3","article-title":"Staging of the estrous cycle and induction of estrus in experimental rodents: an update","volume":"6","author":"Ajayi","year":"2020","journal-title":"Fertil Res Pract"},{"key":"10.1016\/j.ejphar.2023.176119_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/13543776.2021.1910237","article-title":"Steroid sulfatase inhibitors: the current landscape","volume":"31","author":"Anbar","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2023.176119_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183506","article-title":"Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis","volume":"12","author":"Araujo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.176119_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.abb.2019.06.009","article-title":"Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: targeting mitochondrial approach (selenium in PCOS)","volume":"671","author":"Atef","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2023.176119_bib5","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2023.176119_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","article-title":"The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology","volume":"18","author":"Balen","year":"2004","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ejphar.2023.176119_bib7","first-page":"1","article-title":"Measurement of nitric oxide by reconversion of nitrate\/nitrite to NO","volume":"279","author":"Berkels","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.176119_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1183\/09031936.06.00131304","article-title":"Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels","volume":"27","author":"Borgel","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejphar.2023.176119_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3181\/00379727-153-39486","article-title":"Effect of estradiol on uterine weight, thyroid function food intake, and pituitary weight of genetically obese (fatty-Zucker) and lean rats","volume":"153","author":"Bray","year":"1976","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ejphar.2023.176119_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.pharep.2013.11.008","article-title":"Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes\/macrophages","volume":"66","author":"Buldak","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2023.176119_bib11","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2023.176119_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejphar.2023.176119_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005552.pub2","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2023.176119_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1042\/BCJ20160124","article-title":"Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle","volume":"473","author":"Dupont","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2023.176119_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1742-2094-9-74","article-title":"Etiology of autistic features: the persisting neurotoxic effects of propionic acid","volume":"9","author":"El-Ansary","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2023.176119_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3343\/alm.2022.42.1.3","article-title":"Hormone Immunoassay interference: a 2021 update","volume":"42","author":"Ghazal","year":"2022","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.ejphar.2023.176119_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.AOG.0000104485.44999.C6","article-title":"Polycystic ovary syndrome","volume":"103","author":"Guzick","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2023.176119_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119485","article-title":"2-Methoxyestradiol-3,17-O,O-bis-sulfamate inhibits store-operated Ca2+ entry in T lymphocytes and prevents experimental autoimmune encephalomyelitis","volume":"1870","author":"Hosang","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2023.176119_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bmcl.2013.12.018","article-title":"Synthesis of tricyclic fused coumarin sulfonates and their inhibitory effects on LPS-induced nitric oxide and PGE2 productions in RAW 264.7 macrophages","volume":"24","author":"Jang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2023.176119_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000494300","article-title":"Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model","volume":"27","author":"Karateke","year":"2018","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.ejphar.2023.176119_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fendo.2018.00735","article-title":"An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (PCOS): post-pubertal improve PCOS's features","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5468\/ogs.2013.56.3.137","article-title":"Dyslipidemia in women with polycystic ovary syndrome","volume":"56","author":"Kim","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.ejphar.2023.176119_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exmp.2002.2449","article-title":"Experimental hyperlipidemia and the effect of NSAIDs","volume":"73","author":"Kourounakis","year":"2002","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2023.176119_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/humrep\/15.1.21","article-title":"Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome","volume":"15","author":"la Marca","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejphar.2023.176119_bib26","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/1933719116667606","article-title":"Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome","volume":"24","author":"Li","year":"2017","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejphar.2023.176119_bib62","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/jm060705x","article-title":"2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity","volume":"49","author":"Leese","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176119_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003934","article-title":"Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial","volume":"3","author":"Li","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejphar.2023.176119_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","article-title":"Dyslipidemia involvement in the development of polycystic ovary syndrome","volume":"58","author":"Liu","year":"2019","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2023.176119_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/en.2012-1693","article-title":"Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age","volume":"154","author":"Maliqueo","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2023.176119_bib30","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manneras","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2023.176119_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S1519-69842002000400008","article-title":"Determination of the estrous cycle phases of rats: some helpful considerations","volume":"62","author":"Marcondes","year":"2002","journal-title":"Braz. J. Biol."},{"key":"10.1016\/j.ejphar.2023.176119_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/clinchem\/29.3.538","article-title":"A peroxidase-coupled method for the colorimetric determination of serum triglycerides","volume":"29","author":"McGowan","year":"1983","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2023.176119_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13048-015-0203-x","article-title":"Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats","volume":"8","author":"Mesbah","year":"2015","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ejphar.2023.176119_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/clinchem\/48.2.236","article-title":"Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation","volume":"48","author":"Nauck","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2023.176119_bib35","first-page":"336","article-title":"Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches","volume":"38","author":"Ndefo","year":"2013","journal-title":"P T"},{"key":"10.1016\/j.ejphar.2023.176119_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/1078-0432.CCR-07-1717","article-title":"STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells","volume":"14","author":"Newman","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2023.176119_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.176119_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-018-0442-y","article-title":"Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis","volume":"10","author":"Pan","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2023.176119_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/mt.2013.239","article-title":"Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis","volume":"22","author":"Patel","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2023.176119_bib60","doi-asserted-by":"crossref","first-page":"T233","DOI":"10.1530\/JME-18-0045","article-title":"SULFATION PATHWAYS: steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects","volume":"61","author":"Potter","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib41","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/humrep\/dem308","article-title":"Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy","volume":"23","author":"Purohit","year":"2008","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ejphar.2023.176119_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2004-0003","article-title":"Steroid sulfatase: molecular biology, regulation, and inhibition","volume":"26","author":"Reed","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2023.176119_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03347801","article-title":"Arachidonic acid and its metabolites effects on testosterone production by rat Leydig cells","volume":"18","author":"Romanelli","year":"1995","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ejphar.2023.176119_bib44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2023.176119_bib65","first-page":"163","article-title":"New alternative herbal remedies for treatment of letrozole-induced polycystic ovary syndrome in rats","volume":"13","author":"Shehab","year":"2023","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2023.176119_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.30802\/AALAS-JAALAS-19-000084","article-title":"Review of rodent euthanasia methods","volume":"59","author":"Shomer","year":"2020","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.ejphar.2023.176119_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1742-1241.2008.01877.x","article-title":"Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome","volume":"63","author":"Soares","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejphar.2023.176119_bib47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2023.176119_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1091147","article-title":"Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: association with PI3K signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0960-0760(00)00062-5","article-title":"Steroid sulfatase inhibitor alters blood pressure and steroid profiles in hypertensive rats","volume":"73","author":"Valigora","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.176119_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/gcen.1993.1065","article-title":"Arachidonic acid and prostaglandin E2 stimulate testosterone production by goldfish testis in vitro","volume":"90","author":"Wade","year":"1993","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.176119_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters","year":"2008","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2023.176119_bib52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13048-019-0585-2","article-title":"Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase","volume":"12","author":"Wang","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ejphar.2023.176119_bib53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11883-001-0079-7","article-title":"Measurement of cholesterol in plasma and other body fluids","volume":"3","author":"Warnick","year":"2001","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.ejphar.2023.176119_bib54","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent Girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ejphar.2023.176119_bib63","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1074-5521(00)00023-5","article-title":"Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates","volume":"7","author":"Woo","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2023.176119_bib55","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1507\/endocrj.EJ21-0480","article-title":"Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K\/AKT\/mTOR pathway","volume":"69","author":"Xu","year":"2022","journal-title":"Endocr. J."},{"key":"10.1016\/j.ejphar.2023.176119_bib56","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2009-0751","article-title":"Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis","volume":"151","author":"Yang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2023.176119_bib57","first-page":"1345","article-title":"Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome","volume":"11","author":"Yang","year":"2015","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejphar.2023.176119_bib58","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/jog.14730","article-title":"Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K\/AKT pathway","volume":"47","author":"Yu","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ejphar.2023.176119_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2017.03.023","article-title":"Metformin ameliorates uterine defects in a rat model of polycystic ovary syndrome","volume":"18","author":"Zhang","year":"2017","journal-title":"EBioMedicine"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923006337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:24:13Z","timestamp":1757978653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923006337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":63,"alternative-id":["S0014299923006337"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176119","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176119"}}